These encouraging observations were backed up by several studies that have shown beneficial effects of chronic selective ETA blockers (115, 116) or dual ETA/ETB receptor antagonists (117) in experimental CHF, as was evident by relieving sodium retention and mitigating renal hypo filtration. Here, EDNRA is linked to congestive heart failure.